...
首页> 外文期刊>Lipids in Health Disease >Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration
【24h】

Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration

机译:凝块形成过程中血小板释放的鞘氨醇1磷酸酯:血小板计数与血清鞘氨醇1磷酸酯浓度之间密切相关

获取原文
           

摘要

Background Sphingosine 1-phosphate (Sph-1-P), abundantly stored in platelets and released extracellularly upon activation, plays important roles as an extracellular mediator by interacting with specific cell surface receptors, especially in the area of vascular biology and immunology/hematology. Although the plasma Sph-1-P level is reportedly determined by red blood cells (RBCs), but not platelets, this may not be true in cases where the platelets have been substantially activated. Methods and results We measured the Sph-1-P and dihydrosphingosine 1-phosphate (DHSph-1-P) levels in serum samples (in which the platelets had been fully activated) from subjects with (n = 21) and without (n = 33) hematological disorders. We found that patients with essential thrombocythemia exhibited higher serum Sph-1-P and DHSph-1-P concentrations. The serum Sph-1-P concentration was closely correlated with the platelet count but was very weakly correlated with the RBC count. Similar results were obtained for DHSph-1-P. The serum Sph-1-P and DHSph-1-P levels were inversely correlated with the level of autotaxin (ATX), a lysophosphatidic acid-producing enzyme. A multiple regression analysis also revealed that the platelet count had the greatest explanatory impact on the serum Sph-1-P level. Conclusions Our present results showed close correlations between both the serum Sph-1-P and DHSph-1-P levels and the platelet count (but not the RBC count); these results suggest that high concentrations of these sphingoid base phosphates may be released from platelets and may mediate cross talk between platelet activation and the formation of atherosclerotic lesions.
机译:背景信息鞘氨醇1-磷酸酯(Sph-1-P)大量储存在血小板中,并在活化后释放到细胞外,通过与特定的细胞表面受体相互作用,特别是在血管生物学和免疫学/血液学领域,起着细胞外介体的作用。虽然血浆Sph-1-P水平据报道是由红细胞(RBC)决定的,但不是由血小板决定的,但在血小板已被充分激活的情况下,情况可能并非如此。方法和结果我们在有(n = 21)和没有(n = 21)的受试者的血清样本(其中的血小板已完全活化)中测量了Sph-1-P和1-磷酸二氢鞘氨醇(DHSph-1-P)的水平。 33)血液系统疾病。我们发现患有原发性血小板增多症的患者表现出较高的血清Sph-1-P和DHSph-1-P浓度。血清Sph-1-P浓度与血小板计数密切相关,而与RBC计数非常弱相关。对于DHSph-1-P,获得了相似的结果。血清Sph-1-P和DHSph-1-P的水平与溶血磷脂酸产生酶autotaxin(ATX)的水平呈负相关。多元回归分析还显示,血小板计数对血清Sph-1-P水平具有最大的解释性影响。结论我们目前的结果显示血清Sph-1-P和DHSph-1-P水平与血小板计数(而非RBC计数)密切相关。这些结果表明,高浓度的这些类鞘氨醇磷酸酯可能会从血小板中释放出来,并可能介导血小板活化与动脉粥样硬化病变形成之间的串扰。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号